Advanced Prostate Research at Henry Ford

Imagine using the devastating power of cancer cells against themselves. Well, that's exactly what basic and clinical researchers at the Henry Ford Department of Radiation Oncology and the Vattikuti Urology Institute are doing with "suicide" gene therapy studies that cause cancer cells to self-destruct.

Evalutions and advanced reasearch includes;

Determining whether aggressive surgical treatment of prostate cancer improves survival compared to radiation therapy or watchful waiting, with research focused on improvements in surgical removal of the prostate through the development of a robot-assisted laparoscopic radical prostatectomy with 3-D visualization
Determining prostate cancer causes and outcome predictions, especially in relationship to the male hormone testosterone and polymorphic genes
Identifying steroid hormone regulated events that are fundamental to prostate cancer cell growth and the mechanism by which androgen receptor (AR) can regulate that growth
Identifying mRNA-based molecular markers that provide a novel and highly precise description of tumor cells for diagnosis and treatment of prostate cancer
Researching the role of dietary fat in the regulation of prostate cancer cell growth and apoptosis

Advanced Prostate Research

Research by Doctor

Research on Why Robotic Prostate Surgery Works
Studying the merits and value of robotic assisted laprascopic prostatecomy compared to traditional prostate surgeries.

Video: New Prostate Cancer Surgery Has Few Side Effects

Comparing Robotic Vs. Open Prostate Surgery
Enhancing the advantages of laparoscopic prostate surgery.

The urologists at the Vattikuti Urology Institute specialize in the world's most advanced treatments of prostate cancer. The staff treats more than 3,000 men with prostate cancer annually and performs more than 200 surgeries to remove cancer each year.

Advanced prostate research